Ligand Pharmaceuticals (LGND) Tax Provisions (2010 - 2026)
Ligand Pharmaceuticals (LGND) posted Tax Provisions of -$10.9 million for Q1 2026, down 190.98% sequentially from $12.0 million in Q4 2025, and down 41.21% YoY from -$18.6 million in Q1 2025.
Ligand Pharmaceuticals (LGND) Tax Provisions (2010 - 2026) Analysis & Trends
Ligand Pharmaceuticals has reported Tax Provisions for 17 years, with the latest figure at -$10.9 million in Q1 2026.
- Quarterly Tax Provisions fell 41.21% year-over-year to -$10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.3 million (up 209.95% YoY) and the FY2025 annual result came in at $34.5 million, up 426.82% from the prior year.
- Tax Provisions eased to -$10.9 million in Q1 2026 per LGND's latest filing, from $12.0 million in the prior quarter.
- Over five years, Tax Provisions peaked at $38.7 million in Q4 2022 and troughed at -$13.5 million in Q2 2024.
- A 5-year average of $4.8 million and a median of $881000.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions plunged 1629.97% in 2024, then soared 2764.83% in 2025.
- Over 5 years, Tax Provisions stood at $38.7 million in 2022, then sank by 102.82% to -$1.1 million in 2023, then slumped by 643.54% to -$8.1 million in 2024, then soared by 247.88% to $12.0 million in 2025, then sank by 190.98% to -$10.9 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$10.9 million, $12.0 million, and $23.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn | 15.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.80 Mn |
| Mar 31, 2026 | -10.91 Mn |
| Dec 31, 2025 | 12.00 Mn |
| Sep 30, 2025 | 23.86 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Mar 31, 2025 | -7.73 Mn |
| Dec 31, 2024 | -8.11 Mn |
| Sep 30, 2024 | 833,000.00 |
| Jun 30, 2024 | -13.48 Mn |
| Mar 31, 2024 | 27.31 Mn |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | -1.87 Mn |
| Jun 30, 2023 | 881,000.00 |
| Mar 31, 2023 | 11.92 Mn |
| Dec 31, 2022 | 38.67 Mn |
| Sep 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | -3.94 Mn |
| Mar 31, 2022 | 3.79 Mn |
| Dec 31, 2021 | 4.08 Mn |
| Sep 30, 2021 | 1.54 Mn |